Article Details
Retrieved on: 2022-01-23 13:35:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
9 Meters Biopharma, Inc. (NASDAQ:NMTR) has been assigned a consensus rating of "Buy" from the eight research firms that are currently covering the ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here